STOCK TITAN

Veeva Systems Inc. - VEEV STOCK NEWS

Welcome to our dedicated page for Veeva Systems news (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Systems stock.

Veeva Systems Inc. (NYSE: VEEV) is a global leader in cloud-based software solutions specifically tailored for the life sciences industry. Headquartered in the San Francisco Bay Area, Veeva Systems provides innovative technology that helps pharmaceutical and biotech companies streamline their operations, ensure compliance, and bring products to market faster. Veeva's product offerings address key operational and regulatory needs, ranging from customer relationship management (CRM) to content management and data analytics.

Two of the company's flagship products include Veeva CRM and Veeva Vault. Veeva CRM is designed for companies with a salesforce, providing tools to manage customer interactions more efficiently. Meanwhile, Veeva Vault is a versatile content management platform that supports various functions such as clinical trials, regulatory submissions, and quality management within life sciences companies.

Veeva serves a diverse customer base, ranging from emerging biotechs to some of the world's largest pharmaceutical companies. Its commitment to product excellence, customer success, and continuous innovation is evident as Veeva frequently updates its offerings to meet the evolving needs of the industry. Recently, Veeva announced that Boehringer Ingelheim has selected Veeva Vault Clinical and Veeva Vault RIM applications to streamline clinical execution and improve regulatory management in its animal health business unit.

Another notable achievement for Veeva was the launch of the Veeva AI Partner Program, designed to help partners integrate Generative AI solutions seamlessly with Veeva Vault applications. This initiative highlights Veeva's ongoing efforts to leverage advanced technologies to enhance its product ecosystem. Furthermore, the introduction of Veeva Vault CRM Campaign Manager aims to simplify and speed up non-personal promotion to healthcare professionals, ensuring consistent and compliant marketing efforts.

Financially, Veeva Systems has shown strong performance with its fiscal year 2024 results reflecting robust growth. The company continues to invest in its innovation engine and strategic partnerships, setting the stage for sustained, profitable growth. Veeva's recent financial outlook for fiscal year 2025 and first quarter results for 2024 further underline its market leadership and operational excellence.

For more information about Veeva Systems, its products, and latest updates, visit www.veeva.com.

Rhea-AI Summary
Veeva Systems Inc. reports Q2 2023 revenues of $590.2M, up 10% YoY. Subscription services revenues also increase by 10% YoY to $470.6M. Net income increases by 23% YoY to $111.6M. Positive financial performance ahead of guided metrics. Fiscal 2024 Q3 revenue guidance of $614-616M. Fiscal 2024 revenue guidance of $2,365-2,370M. Fiscal 2025 revenue guidance of at least $2,800M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.36%
Tags
-
Rhea-AI Summary
Veeva Systems announces major milestones for Vault CRM in the life sciences industry. First customer win with an oncology biotech, plans for general release in April 2024. Veeva CRM solution on Salesforce platform to enter stability mode in December 2023. Veeva CRM will be supported until September 2030.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
none
-
Rhea-AI Summary
Civica Rx adopts Veeva Vault LIMS to optimize quality control, improving productivity and speed with a unified quality ecosystem.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.42%
Tags
none
Rhea-AI Summary
Veeva Systems announced that Amgen, Bristol Myers Squibb, Daiichi Sankyo, Merck, and Takeda will be keynote speakers at the upcoming 2023 Veeva R&D and Quality Summit in Boston. The event will focus on new strategies and technology in the life sciences industry, with over 2,000 executives expected to attend. Veeva CEO Peter Gassner will kick off the opening keynote. The event aims to facilitate networking, industry trend discussions, and the discovery of new technologies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.25%
Tags
none
-
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) to announce its second-quarter financial results on August 30, 2023, followed by a conference call and webcast to discuss the outcomes. Prepared remarks will be posted on its investor relations website, with a webcast replay available after the live event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.03%
Tags
-
Rhea-AI Summary
Veeva Systems reveals findings of field medical's impact on clinical practice, showing that engagement with key opinion leaders (KOLs) before launch leads to 1.5 times greater treatment adoption. However, 70% of KOLs only engage with one biopharma, indicating a need for greater field planning and connected insights.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.59%
Tags
none
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) announced that Merck KGaA, Darmstadt, Germany is using Veeva Vault MedInquiry as its global medical information management system. Vault MedInquiry streamlines global medical information requests, improves scientific exchange, and ensures compliance, with a focus on user experience and performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.1%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.72%
Tags
partnership
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.31%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.31%
Tags
conferences

FAQ

What is the current stock price of Veeva Systems (VEEV)?

The current stock price of Veeva Systems (VEEV) is $217.43 as of December 24, 2024.

What is the market cap of Veeva Systems (VEEV)?

The market cap of Veeva Systems (VEEV) is approximately 35.3B.

What does Veeva Systems Inc. do?

Veeva Systems Inc. provides cloud-based software solutions for the global life sciences industry, including tools for CRM, content management, and data analytics.

Where is Veeva Systems Inc. headquartered?

Veeva Systems Inc. is headquartered in the San Francisco Bay Area.

What are Veeva's main products?

Veeva's main products include Veeva CRM, a customer relationship management platform, and Veeva Vault, a content management platform.

Who are Veeva Systems' customers?

Veeva Systems serves over 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs.

What recent partnerships has Veeva announced?

Recently, Veeva announced a partnership with Boehringer Ingelheim, which selected Veeva Vault Clinical and Veeva Vault RIM for its animal health business unit.

What is the Veeva AI Partner Program?

The Veeva AI Partner Program provides partners with technology and support to integrate Generative AI solutions seamlessly with Veeva Vault applications.

How has Veeva performed financially recently?

Veeva has reported strong financial results for fiscal year 2024 and continues to show robust growth and operational excellence.

What is Veeva Vault CRM Campaign Manager?

Veeva Vault CRM Campaign Manager is a new marketing application that simplifies and speeds non-personal promotion to healthcare professionals, ensuring consistency and compliance.

What industry does Veeva Systems primarily serve?

Veeva Systems primarily serves the life sciences industry.

How does Veeva contribute to the life sciences industry?

Veeva helps life sciences companies streamline operations, ensure compliance, and bring products to market faster through its innovative cloud-based software solutions.

Veeva Systems Inc.

NYSE:VEEV

VEEV Rankings

VEEV Stock Data

35.30B
147.87M
8.94%
83.88%
1.45%
Health Information Services
Services-prepackaged Software
Link
United States of America
PLEASANTON